Neogen Corporation (NEOG) Guidance & Earnings Results

On 2026-10-06 Neogen Corporation raised guidance: "FY27 revenue raised to $885-890M; Adjusted EBITDA raised to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason

NEOGNeogen CorporationFollow NEOG — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 2.7B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 6 Jan, in 74 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Oct 26	Raised	FY27 revenue raised to $885-890M; Adjusted EBITDA raised to $181-183M. · full year
30 Jul 26	Raised	FY2027 revenue and Adjusted EBITDA guidance provided; specific numbers not disclosed in excerpt. · full year
9 Apr 26	Raised	FY26 revenue outlook raised; Adjusted EBITDA guidance maintained. · full year
8 Jan 26	Raised	Revenue guidance raised to $845-855M (from $820-840M); Adjusted EBITDA raised to ~$175M (from $165-175M) · full year
9 Oct 25	Reaffirmed	Revenue $820-840M; Adjusted EBITDA $165-175M; Capex ~$50M · full year
29 Jul 25	Lowered	FY2026 revenue $820-840M; Adjusted EBITDA $165-175M; capex ~$50M · full year

Neogen Corporation — questions

What guidance did Neogen Corporation give?: On 2026-10-06: "FY27 revenue raised to $885-890M; Adjusted EBITDA raised to $181-183M."
When does Neogen Corporation report earnings?: Neogen Corporation's next earnings report is expected on 2027-01-06.

Every figure on this page comes from Neogen Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.